The role of pirfenidone in the treatment of interstitial pneumonia with autoimmune features

CONCLUSIONS: Pirfenidone (600-1,800 mg/day) might help improve FVC, with an acceptable safety and tolerability profile in IPAF patients.PMID:33822701

Source: Clinical and Experimental Rheumatology - April 6, 2021 Category: Rheumatology Authors: Tao Chen Qiu-Hong Li Yuan Zhang Cheng-Sheng Yin Dong Weng Ying Zhou Yang Hu Jing-Yun Shi Ya-Nan Chen Shuang Ye Xiao-Dong Wang Chun-Yan Wu Yan Huang Ai-Hong Zhang Hui-Ping Li Source Type: research